COVID-19 and Multiorgan Response: The Long-Term Impact

Area of Science:

• Infectious Diseases
• Pathophysiology
• Public Health

Background:

• Severe acute respiratory syndrome coronavirus type-2 (SARS-CoV-2) emerged in late 2019, leading to the COVID-19 pandemic.
• Early in the pandemic, the multiorgan impact of SARS-CoV-2 was not fully understood.
• Over 750 million global cases highlight the complexity of COVID-19's pathophysiology.

Purpose of the Study:

• To examine the long-term effects of COVID-19 on multiple organ systems.
• To analyze changes in the clinical management of COVID-19 patients.
• To identify areas needing clearer guidelines for managing severe COVID-19.

Main Methods:

• Review of existing literature on COVID-19 pathophysiology and clinical manifestations.
• Analysis of disease presentation, management strategies, and outcomes.
• Synthesis of current understanding of SARS-CoV-2's impact on cardiovascular, respiratory, urinary, gastrointestinal, and vascular systems.

Main Results:

• COVID-19 is a multifaceted disease with significant long-term impacts on major organ systems.
• Theories for SARS-CoV-2 pathophysiology include direct viral infection, coagulation dysfunction, cytokine storm, and complement system activation.
• Disease presentation and management have evolved considerably since the pandemic's onset.

Conclusions:

• Clearer guidelines for pharmacological, non-pharmacological, and psychological management are needed for severe COVID-19.
• Improved management strategies are essential to enhance survival rates and long-term outcomes.
• Continued research is vital to fully understand and address the complex impacts of SARS-CoV-2 infection.